WallStreetZenWallStreetZen

NASDAQ: BTMD
Biote Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Biote earnings were $15.6M for the trailing 12 months ending Mar 31, 2026, with -27.9% growth year over year. The latest BTMD earnings report on Mar 31, 2026 announced Q1 2026 earnings of $2.3M, up 16.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BTMD reported annual earnings of $27.0M, with 756.7% growth. The next BTMD earnings date is Aug 5, 2026.

BTMD past earnings growth

How has BTMD's earnings growth performed historically?

Company
-27.94%
Industry
68.16%
Market
83.64%
BTMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BTMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

BTMD earnings history

Current Revenue
$188.2M
Current Earnings
$15.6M
Current Profit Margin
8.3%

BTMD Return on Equity

Current Company
-22.9%
Current Industry
-53.8%
Current Market
13.5%
BTMD's Return on Equity (-22.9%)... subscribe to Premium to read more.
High Return on Equity Performance

BTMD Return on Assets

Current Company
15.1%
Current Industry
7.8%
BTMD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BTMD announces earnings.

BTMD Return on Capital Employed

Current Company
50.43%
Current Industry
17.5%
BTMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BTMD vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BTMD$35.01M$15.60M-67.47%$0.49
PIII$10.97M-$126.25MN/A-$38.61
PARKN/AN/AN/AN/A
NAKA-$277.41M-$289.97MN/A-$6.80
DCGO-$159.68M-$187.76MN/A-$1.89
View Top Medical Care Facility Stocks

BTMD earnings dates

Next earnings date
Aug 5, 2026

Biote Earnings Reports & History FAQ

What were Biote's earnings last quarter?

On BTMD's earnings call on Invalid Date, Biote (NASDAQ: BTMD) reported Q1 2026 earnings per share (EPS) of $0.07, up 84.09% year over year. Total BTMD earnings for the quarter were $2.28 million. In the same quarter last year, Biote's earnings per share (EPS) was $0.44.

If you're new to stock investing, here's how to buy Biote stock.

When does Biote report earnings?

The next BTMD earnings date is Invalid Date. Add BTMD to your watchlist to be reminded of Biote's next earnings date.

Is Biote profitable or losing money?

As of the last Biote earnings report, Biote is currently profitable. Biote's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $15.60 million, a 25.82% decrease year over year.

What was BTMD's earnings growth in the past year?

As of Biote's earnings date in Invalid Date, Biote's earnings has grown -27.94% year over year. This is 96.1 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 68.16%. BTMD earnings in the past year totalled $15.60 million.

What are Biote's earnings expectations?

The current EPS estimate for Biote's earnings report in Invalid Date is $0.07.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.